Soren M Bentzen

Citirano

	Sve	Od 2019.
Citati	51551	18257
H-indeks	114	63
i10-indeks	410	262

3400

1700

850

2550

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202 228 258 284 310 424 445 503 474 541 684 648 823 1010 1292 1402 1405 1690 1795 2069 2376 2384 2599 2641 2620 2987 2815 3273 3333 3230 2796 2775

Javni pristup

Prikaži sve

140 članaka

21 članak

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Ivan VogeliusClinical Professor at Dept. of Oncology, Rigshospitalet & Faculty of Health Sciences, CopenhagenPotvrđena adresa e-pošte na regionh.dk
Minesh MehtaMiami Cancer InstitutePotvrđena adresa e-pošte na fiu.edu
Joseph O. Deasy, PhDMemorial Sloan Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
Philippe LambinProfessor of Precision Medicine, Maastricht University & Scientist ULBPotvrđena adresa e-pošte na maastrichtuniversity.nl
Wolfgang A. ToméProfessor, Albert Einstein College of MedicinePotvrđena adresa e-pošte na einsteinmed.edu
Marianne AznarProfessor of Radiation Oncology Physics, University of ManchesterPotvrđena adresa e-pošte na manchester.ac.uk
Pranshu Mohindra, MD, MMM, MBBS,...University Hospitals Seidman Cancer Center, Cleveland, OhioPotvrđena adresa e-pošte na uhhospitals.org
Bradly WoutersPrincess Margaret Cancer Centre, University Health Network, University of TorontoPotvrđena adresa e-pošte na uhn.ca
Olfred HansenProfessor, Dept. of Oncology, Odense University HospitalPotvrđena adresa e-pošte na rsyd.dk
Simon BondCambridge Clinical Trials Unit, MRC Biostatistics UnitPotvrđena adresa e-pošte na addenbrookes.nhs.uk
Ane L AppeltUniversity of Leeds and St James’s University HospitalPotvrđena adresa e-pošte na leeds.ac.uk
Carsten BrinkProfessor at University of Southern DenmarkPotvrđena adresa e-pošte na rsyd.dk
Nils Patrik BrodinMontefiore Medical Center and Albert Einstein College of Medicine, New YorkPotvrđena adresa e-pošte na einsteinmed.org
Francesca BuffaProfessor Computing Sciences @Bocconi University - CBIG Lab @Oxford University - AI Lab @IFOM MilanPotvrđena adresa e-pošte na unibocconi.it
Prof. Anwar PadhaniPaul Strickland scanner centre, Northwood, Middlesex. UKPotvrđena adresa e-pošte na stricklandscanner.org.uk
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Potvrđena adresa e-pošte na maastro.nl
Paul PharoahCedars-Sinai Medical CenterPotvrđena adresa e-pošte na cshs.org
Matthew R SydesMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University CollegePotvrđena adresa e-pošte na ucl.ac.uk
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityPotvrđena adresa e-pošte na oncology.ox.ac.uk
Anders BertelsenPh.D. Medical Physicist @ Odense University Hospital, DenmarkPotvrđena adresa e-pošte na rsyd.dk

Prati

Soren M Bentzen

Professor of Epidemiology and Public Health

Potvrđena adresa e-pošte na som.umaryland.edu - Početna stranica

Biostatistics oncology evidence based medicine medical physics mathematical modeling


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Use of normal tissue complication probability models in the clinic LB Marks, ED Yorke, A Jackson, RK Ten Haken, LS Constine, A Eisbruch, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S10-S19, 2010	2170	2010
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study GC Barnett, CE Coles, RM Elliott, C Baynes, C Luccarini, D Conroy, ... The Lancet Oncology, 2011	1822	2011
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues SM Bentzen, LS Constine, JO Deasy, A Eisbruch, A Jackson, LB Marks, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S3-S9, 2010	1418	2010
Radiation dose-volume effects in the lung LB Marks, SM Bentzen, JO Deasy, FMS Kong, JD Bradley, IS Vogelius, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S70-S76, 2010	1284	2010
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial YJR Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM ... Lancet 371 (9618), 1098-1107, 2008	1232*	2008
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology SM Bentzen Nature Reviews Cancer 6 (9), 702-713, 2006	1232	2006
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study M Nordsmark, SM Bentzen, V Rudat, D Brizel, E Lartigau, P Stadler, ... Radiotherapy and Oncology 77 (1), 18-24, 2005	1156	2005
Overgaard J (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study M Nordsmark, SM Bentzen, V Rudat, D Brizel, E Lartigau, P Stadler, ... Radiother Oncol 77, 18-24, 0	1156*
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial TS Trialists' Group The lancet oncology 9 (4), 331, 2008	1147	2008
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ... Neuro-oncology 15 (10), 1429-1437, 2013	970	2013
Radiation oncology in the era of precision medicine M Baumann, M Krause, J Overgaard, J Debus, SM Bentzen, J Daartz, ... Nature Reviews Cancer 16 (4), 234-249, 2016	877	2016
Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial JR Owen, A Ashton, JM Bliss, J Homewood, C Harper, J Hanson, ... The lancet oncology 7 (6), 467-471, 2006	783	2006
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma J Overgaard, SM Bentzen, DG Gonzalez, M Hulshof, G Arcangeli, O Dahl, ... The Lancet 345 (8949), 540-543, 1995	752	1995
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial J Yarnold, A Ashton, J Bliss, J Homewood, C Harper, J Hanson, ... Radiotherapy and oncology 75 (1), 9-17, 2005	637	2005
Theragnostic imaging for radiation oncology: dose-painting by numbers SM Bentzen The lancet oncology 6 (2), 112-117, 2005	532	2005
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline BD Smith, SM Bentzen, CR Correa, CA Hahn, PH Hardenbergh, GS Ibbott, ... International Journal of Radiation Oncology* Biology* Physics, 2010	500	2010
Time-dose factors in radiotherapy: a review of the human data HD Thames, SM Bentzen, I Turesson, M Overgaard, W Van den Bogaert Radiotherapy and Oncology 19 (3), 219-235, 1990	494	1990
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study R Pötter, K Tanderup, MP Schmid, I Jürgenliemk-Schulz, C Haie-Meder, ... The Lancet Oncology 22 (4), 538-547, 2021	442	2021
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ... Journal of clinical oncology 24 (7), 1057-1063, 2006	427	2006
Timing of chest radiation with respect to combination chemotherapy in small cell lung cancer, limited disease HP Schultz, OS Nielsen, A Sell, S Steenholdt, S Bentzen Lung Cancer 4, 153, 1988	412*	1988

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori